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Abstract: Worldwide, antimicrobial resistance is increasing rapidly and is associated with misuse 
of antimicrobials. The HATUA study (a broader 3-country study) investigated the antibiotic dis-
pensing practices of pharmaceutical providers to clients, particularly the propensity to dispense 
without prescription. A cross-sectional study using a ‘mystery client’ method was conducted in 
1,148 community pharmacies and accredited drugs dispensing outlets (ADDO) in Mwanza (n = 
612), Mbeya (n = 304) and Kilimanjaro (n = 232) in Tanzania. Mystery clients asked directly for amox-
icillin, had no prescription to present, did not discuss symptoms unless asked [when asked reported 
UTI-like symptoms] and attempted to buy a half course. Dispensing of amoxicillin without pre-
scription was common [88.2, 95%CI 86.3%–89.9%], across all three regions. Furthermore, the major-
ity of outlets sold a half course of amoxicillin without prescription: Mwanza (98%), Mbeya (99%) 
and Kilimanjaro (98%). Generally, most providers in all three regions dispensed amoxicillin on de-
mand, without asking the client any questions, with significant variations among regions [p-value 
= 0.003]. In Mbeya and Kilimanjaro, providers in ADDOs were more likely to do this than those in 
pharmacies but no difference was observed in Mwanza. While the Tanzanian government has laws, 
regulations and guidelines that prohibit antibiotic dispensing without prescription, our study sug-
gests non-compliance by drug providers. Enforcement, surveillance, and the provision of continu-
ing education on dispensing practices is recommended, particularly for ADDO providers. 
Keywords: antibiotic; antibiotic resistance; dispensing practice; prescription 
 
1. Introduction 
Since their discovery in 1928, antibiotics (ABs) have revolutionized treatment of ill-
nesses caused by microorganisms and contributed significantly to decrease in mortality 
Citation: Ndaki, P.M.; Mushi, M.F.; 
Mwanga, J.R.; Konje, E.T.; 
Ntingunya, E.N.; Mmbaga, B.T.; 
Keenan, K.; Sabiiti, W.; Kesby, M.; 
Benitez-Paez, F.; et al. Dispensing 
Antibiotics without Prescription at 
the Community Pharmacies and  
Accredited Drug Dispensing Outlets 
in Tanzania. A Cross-Sectional 
Study. Antibiotics 2021, 10, 1025. 
https://doi.org/10.3390/ 
antibiotics10081025 
Academic Editor: Marianne van der 
Sande 
Received: 5 July 2021 
Accepted: 18 August 2021 
Published: 23 August 2021 
Publisher’s Note: MDPI stays neu-
tral with regard to jurisdictional 
claims in published maps and institu-
tional affiliations. 
 
Copyright: © 2021 by the authors. Li-
censee MDPI, Basel, Switzerland. 
This article is an open access article 
distributed under the terms and con-
ditions of the Creative Commons At-
tribution (CC BY) license (http://crea-
tivecommons.org/licenses/by/4.0/). 
Antibiotics 2021, 10, 1025 2 of 15 
 
 
worldwide. However, the global expansion of ABs use has been paralleled by a similar 
increase in antimicrobial resistance (AMR) [1]. A systematic evaluation of antibiotic con-
sumption by the World Health Organization (WHO) across 76 countries over a 15-year 
period (2000–2015) revealed overall use per capita increased by 26% in the first- and sec-
ond-line therapies and 91% in those used only with specific indication due to high re-
sistance [2]. In Tanzania, between 2017 and 2019, antimicrobial consumption for all anti-
microbials was reported to be 80.8 ± 39.35 defined daily doses (DDDs) per 1000 inhabit-
ants, with amoxicillin having a DDD/1000 of 16.75, ranking second after doxycycline as 
the most commonly consumed antimicrobial. The total consumption was greater than in 
many high-income countries in Europe, Japan and China, however there was no data to 
compare from Sub-Saharan African countries [3,4]. In addition, in 2020, data from six re-
ferral hospitals using a point prevalence survey (PPS) observed that approximately 62.3% 
of inpatients were prescribed antibiotics [5]. Globally, in both healthcare and community 
settings, resistance is increasing in bacteria that cause many common diseases and the 
WHO now lists antimicrobial resistance as one of the top ten threats to global health [6]. 
A 2015 WHO study of 12 low and middle-income countries (LMICs) showed that 
93% of patients obtain antibiotics from medical stores and pharmacies leaving only a mi-
nority who obtain antibiotics directly from health professionals [7]. Furthermore, many 
LMIC patients view drug sellers in small drug shops and community pharmacies, as a 
more accessible first point of call for health care seeking for common disease treatment 
and, crucially, antibiotic provision [8]. Health or care-seeking behavior has been defined 
as any action undertaken by individuals who perceive themselves to have a health prob-
lem or to be ill for the purpose of finding an appropriate remedy [9]. 
Despite prohibitive regulation, there is considerable evidence indicating that ABs are 
commonly dispensed without prescription and/or appropriate advice in many LMICs 
[10]. Over-the-counter medication with ABs can delay hospital admission, mask the diag-
nosis of infectious diseases, and facilitate the development and spread of resistant patho-
gens. The willingness of providers to make ABs available without prescription is itself one 
of the factors that drive over-the-counter medication [11]. 
In Tanzania, several reports have been published that advocate more appropriate, or 
so-called ’rational’ use of antibiotics [12]. Studies conducted on the development of anti-
microbial stewardship programs in Tanzania have stated the need to increase investments 
in the medicine regulatory authority to achieve this [13]. The Tanzania Medicine and Med-
ical Devices Authority (TMDA) which mandates the licensing, monitoring, and regulating 
of drugs in Tanzania, categorizes community pharmacies as either type 1 pharmacies or 
type 2 pharmacies/accredited drugs dispensing outlets (ADDO). Type 1 pharmacies are 
supposed to operate under the supervision of a registered pharmacist, with certain con-
ditions (e.g., air-conditioning, refrigeration of drugs and a dispensing window) and can 
sell all three categories of retail medicines: prescription only (POM) which includes anti-
biotics, pharmacy only (PO), and general sale list (GSL). ADDOs do not require a regis-
tered pharmacist and are supervised by any person who has attended a five weeks’ ADDO 
training course [14]. Another key difference between pharmacies and ADDOs is that the 
latter are more restricted in terms of the drugs they can sell. ADDOs are permitted to sell 
only medicines on the GSL (which includes for example common painkillers, cold and flu 
remedies), and can dispense some antibiotics with prescription, for instance, amoxicillin 
capsule/suspension, benzyl-penicillin powder for injections, chloramphenicol eye drops, 
Trimethoprim/Sulfamethoxazole suspension, doxycycline capsules/tablets, Phe-
noxymethylpenicillin suspension/tablets and procaine penicillin fortified [15]. 
The ADDO program was a donor-initiated project launched in 2003 to improve phar-
maceutical access in underserved communities and aimed to regulate local retail drug 
shops (previously known as maduka ya dawa baridi), which were often located in rural, 
and peri-urban settings [16]. As of 2019, there were 1504 Type 1 registered pharmacies 
and 14,045 ADDOs in Tanzania [17] which are now known in Kiswahili as ‘maduka ya 
dawa muhimu’ (literally, essential medicines shops). Reviews suggest that ADDOs are 
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central to health-seeking behavior, being widely accepted as convenient, reliable, and 
preferable sources of medication by local communities and help to improve antibiotic ac-
cess [18]. However, there are some reports of inappropriate over-dispensing of antimicro-
bials in ADDOs [18]. As self-medication with antimicrobials seems relatively common in 
Tanzania, as in many LMIC settings, the role of ADDOs in fostering antibiotic overuse of 
ABs should be further investigated [19]. 
There have been relatively few studies on community pharmacy and ADDO antibi-
otic provision in Tanzania, and these are limited geographically and dated [20–23]. A mys-
tery client study in the urban area of Moshi (Kilimanjaro, northeast Tanzania) found 92% 
of community pharmacies provide antibiotics without prescription [24], and client exit 
interviews in urban Moshi found three-quarters of antibiotic purchases were made with-
out prescription [22]. Studies evaluating ADDO practices specifically have revealed simi-
larly high rates of inappropriate antibiotic provision. One study of mystery client visits in 
ADDOs across Tanzania found one-third of ADDOs sold antibiotics for cold-like symp-
toms, and 85% sold antibiotics on request without prescription [18]. In 2011, a mystery 
client study of 145 providers in the Morogoro region reported 79% of ADDOs sold drugs 
without prescription [25]. Further evidence is required to assess whether these patterns 
can be generalized to the rest of the country, or if they vary systematically by pharmacy 
type, and between rural and urban areas. Such variation has been observed in other LMIC 
settings including other parts of East Africa [26] and Vietnam [27]. In this paper, we report 
the results of a mystery client study with drug sellers in three different regions of Tanza-
nia, which aimed to investigate variations in antibiotic dispensing practices by area and 
type of pharmacy, and the quality of advice provided by the antibiotic seller. 
2. Materials and Method 
2.1. Study Design 
This study is nested within a wider 3-country interdisciplinary study on the drivers 
of AMR in East Africa (Holistic Approach to Unravel Antibacterial Resistance in East Af-
rica—HATUA), and full details can be read elsewhere [28]. This cross-sectional commu-
nity-based quantitative survey uses mystery client scenarios, sometimes called mystery 
clients or mystery shoppers to assess dispensing practices. Mystery client studies are a 
commonly used tool in LMIC settings to observe drug provider behavior first-hand and 
minimize observation bias (2)]. In our study this involved trained field workers posing as 
clients who visited pharmacies and ADDOs and enacted a scenario that tested a specific 
behavior (in this case AB dispensing practices) [29]. 
2.2. Study areas and Sampling 
This cross-sectional study was carried out in the Mwanza (Nyamagana, Ilemela and 
Sengerema), Mbeya (Mbeya urban and Mbeya rural districts) and Kilimanjaro (Moshi ur-
ban and Moshi rural districts) regions of Tanzania between April and July 2019. The re-
gions and respective districts were purposely selected based on the geographical location 
to cover northeastern Tanzania, northwestern Tanzania and South-western highlands of 
Tanzania [28]. Figure 1 shows the geographical location of regions. The main economic 
activities of Mwanza are subsistence farming, fishing and livestock keeping, while in 
Mbeya and Kilimanjaro they are mainly subsistence farming. Nyamagana and Ilemela 
District form the city of Mwanza (the second largest in Tanzania). Sengerema, Mbeya Dis-
trict Council and Moshi District Council represent the rural population while Ilemela, 
Nyamagana, Mbeya City Council and Moshi Municipal Council represent the urban ar-
eas. 




Figure 1. Location of our three study areas within Tanzania. 
To create a comprehensive sampling frame for the study, we undertook a mapping 
exercise within our study areas (Mwanza 25–29 March, Mbeya 5–9 May and Kilimanjaro 
20–24 May). Teams of trained fieldworkers systematically traversed roads and pedestrian 
areas, recording the location, type of outlet and observable regulatory compliance (e.g., 
display of certificates) of all formal and informal medicine outlets, using GPS-enabled tab-
lets and a report form developed in the research software package Epicollect5 [30]. Figure 
2 shows the locations of retail pharmaceutical outlets. 




Figure 2. Geographical distribution of ADDOs, pharmacies and other drug providers mapped in the three study areas. 
ADDOs and pharmacies were surveyed in the mystery client study. 
The global positioning system (GPS) coordinates generated by the mapping provided 
a list of pharmacies and ADDOs that formed the sample frame for the mystery client 
study. To avoid selection bias and to maximize the sample size, the study aimed to survey 
100% of the previously mapped type 1 community pharmacies and ADDOs. Given the 
focus on human antibiotic provision, we excluded agro vets and alternative/traditional 
medicine shops, and we also excluded 9 shops because they were closed on the day of the 
survey. The survey was piloted in Misungwi district in Mwanza and all entries were re-
viewed to confirm fieldworker compliance with the protocol, and practical challenges 
were addressed before further data collection commenced in April 2019 (Mwanza) and 
May 2019 (Mbeya and Kilimanjaro) using assigned lists from the sample frame to avoid 
repetition. 
2.3. Data Collection 
The mystery clients (MCs) comprised 25 research assistants (10 females and 15 males) 
unknown by the drug sellers, the majority of whom were undergraduate pharmacy stu-
dents and the remainder other health students. MCs received training on the study objec-
tives, protocol and sampling strategy, ethical issues, and the mystery client scenario (see 
the Supplementary Materials S1). Visiting each seller once, MCs requested amoxicillin 
and, unless questioned by the seller, did not describe symptoms (of UTI) or state that they 
did not have a prescription. If the seller refused to sell or advised a non-antibiotic remedy, 
the MCs took that advice and bought what was recommended and left. If the seller was 
willing to dispense amoxicillin in these circumstances or recommended another pharma-
ceutical drug instead or as well, the MCs then requested that they be allowed to buy only 
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a “couple of days’ worth” of the drug(s) to ‘see if their friend’s advice was good/it 
worked’. If the seller insisted they buy a full course, the MCs did so. 
The full course was defined according to the Tanzania Standard Treatment Guide-
lines [15] which state an adult minimum course of amoxicillin of 500 mg 8-hourly for 5 
days which translates to 30 capsules of amoxicillin. In addition, a full course should be 
whatever a doctor had prescribed, and sellers should ask for a prescription before selling 
the antibiotic. After the encounter, fieldworkers moved away from the premises and rec-
orded what transpired, inputting data directly into Epicollect5 on their tablets [30]. 
2.4. Data Analysis 
The results were analyzed using descriptive univariate and bivariate statistics. The 
practice of dispensing across regions was reported as a proportion with a 95% confidence 
interval. 
The main binary outcome of this study was selling amoxicillin without prescription. 
We also created a summary score variable that measured, in the context of the given sce-
nario, the quality of the interaction between client and seller and the degree to which prac-
tices among sellers were in line with AB stewardship programs. We used the following 
list of binary variables: 
(1) either advised buying a full course, or would only sell a full course, (2) asked for 
a prescription, (3) asked if the MC was taking any other medications, (4) suggested that 
the MC did not need antibiotics, (5) recommended that the MC see a doctor and/or get a 
prescription, (6) gave clear instructions (oral or written) that the MC should buy a full 
course (even if they eventually sold a half course) and (7) gave clear instructions (oral or 
written) that the MC should normally finish a full course (even if they eventually sold a 
half course). The scores ranged from 0 to 7. We used bivariate contingency tables to assess 
differentials in these outcomes across the three regions and districts, and by type of phar-
macy. The strength of bivariate associations was tested using Chi-square tests or Fisher’s 
exact tests (depending on cell sample size). The data collected were downloaded from 
Epicollect5 and checked for consistency before being transferred to Stata version 13 (Stata 
Corp., College Station, TX, USA). 
2.5. Ethical Considerations 
The study received ethical approval from the University of St Andrews, UK (No. 
MD14548, 10/09/19); National Institute for Medical Research, Tanzania (No. 2831, updated 
26/07/19), Mbeya Medical Research and Ethics Committee (No. SZEC-2439/R.A/V.1/30), 
Kilimanjaro Christian Medical College, Tanzania (No. 2293, updated 14/08/19) and 
CUHAS/BMC research ethics and review committee (No. CREC /266/2018, updated on 
02/2019). While sellers did not consent, the scenario did not require sellers to do or say 
anything outside of what they would otherwise be doing as part of their usual practice. 
Furthermore, the responses gathered at particular sites and from particular individuals, 
are not identifiable in the data presented. 
3. Results 
3.1. Community Pharmacies and ADDOs in Mwanza, Mbeya and Kilimanjaro  
A total of 612, 304 and 232 community pharmacies and ADDOs were mapped in 
Mwanza, Mbeya, and Kilimanjaro, respectively (Table 1). The population density per 
drug outlet was higher in rural areas than urban areas: the highest densities were found 
in Kilimanjaro rural (4094) followed by Mwanza rural (3489) (Table 1). In rural areas, AD-
DOs outnumbered pharmacies almost 100-fold (except Mbeya where they were 10 to 1), 
and in Urban areas they did so by more than three-fold (except Mwanza). 
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(Average House Size) 







  ADDO PHARMACY Total   
Mwanza     2205.3  
Urban  706453 (4.8)  324 110 434  1600.3 
Rural  663,034 (6.0) 184 3 187  3489.7 
Mbeya     2271.7  
Urban  385,279 (4.2) 142 31 173  1888.6 
Rural  305,319 (4.1) 120 11 131  2150.1 
Kilimanjaro     2593.7  
Urban  184,292 (4.0) 97 23 120  1288.8 
Rural  466,737 (4.2) 110 2 112  4094.2 
3.2. Stocking, Dispensing and Price of Amoxicillin in Mwanza, Mbeya and Kilimanjaro 
Almost all community pharmacies and ADDOs (1084, 94.0%) stocked amoxicillin 
during the study period. This was observed across all three regions: Mwanza (563, 91.0%), 
Mbeya (297, 97.0%), and Kilimanjaro (224, 96.0%). Of these, the majority dispensed amox-
icillin ‘on demand’ without posing any question to the client (see Table 2). Of even greater 
significance, the vast majority in all regions responded positively, without further ques-
tion or comment, to the MC’s request that they dispense ‘only a few days’ worth’. 
The price of one capsule of amoxicillin (250mg) in all regions was 100Tsh (0.043USD). 
The analysis of 708 sellers with full details revealed that the number of capsules dispensed 
in response to MC’s request for ‘a few days’ (half course) varied considerably (1–20 cap-
sules), with a median of 10 capsules (one blister pack) (IQR: 5–10). The number of capsules 
dispensed for a ‘full course’ was consistent (30 capsules) and conformed exactly to Tan-
zanian regulation for a minimum adult course for amoxicillin. Full course without pre-
scription was dispensed in only 6 drug outlets. 
Only a small minority of those prepared to sell a half course told the MC that the 
consumption of a full course was advisable. Very few denied the request and insisted on 
selling a full course (the highest was 8.0% Mwanza). These results were not affected by 
researcher bias; MCs only made one request for a half course and did not attempt to per-
suade the seller. 
Furthermore, across the three sites, whilst no MC held a prescription, an overwhelm-
ing majority of sellers dispensed amoxicillin as requested by the MC [88.2%, 95%CI 86.3–
89.9%], although there was some significant variation by region [Mwanza, 85.3%, 95%CI 
82.3–87.9%, Mbeya, 90.3%, 95%CI 86.6–93.3% and Kilimanjaro, 93.1%, 95%CI 89.0–95.7%] 
and this difference (between Mwanza compared to Mbeya and Kilimanjaro) was statisti-
cally significant (chi2 = 11.851 and p-value = 0.003). 
Table 2. Sellers’ dispensing practice and quality of interaction across the three regions. 
Seller Response when Directly 
Asked to Sell a Half Course of 
Amoxicillin 
Mwanza 
(n = 612) 
Mbeya 
(n = 304) 
Kilimanjaro  
(n = 232) 
TOTAL 
(n = 1148) 
Chi-Square and p 
Value 
Did not sell amoxicillin a 47(7.7) 3(1.0) 7(3.0) 57(4.9) 
Pearson chi2(2) = 
21.267, Pr = 0.000  
Sold half course without questions 509(83.2) 276(90.8) 216(93.1) 1001(87.2) 
Pearson chi2(2) = 
19.652 Pr =0.000 
Sold half course but advised full 
course 
45(7.4) 22(7.2) 6(2.6) 73(6.4) 
Pearson chi2, 6.9546   
Pr = 0.031 
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Would only sell a full course 11(1.8) 3(1.0) 3(1.3) 17(1.5) Fisher's exact = 0.554 
Quality of interaction by item      
Asked about prescription 9 (1.5) 2 (0.7) 3 (1.3) 14 (1.2) Fisher’s exact = 0.631 
Asked to describe symptoms 54 (8.8) 16 (5.3) 13 (5.6) 83 (7.22) 
Pearson chi2(2) = 
5.851 Pr = 0.054 
Asked about taking other medications 10 (1.6) 4 (1.3) 3 (1.3) 17 (1.5) Fisher’s exact = 1.000 
Suggested no need of antibiotics 5 (0.8) 1 (0.3) 3 (1.3) 9(0.8) Fisher’s exact = 0.492 
Suggested to see a doctor 11 (1.8) 0 9 (3.9) 20(1.7) Fisher’s exact = 0.001 
Provided instruction to buy a full 
course 
49 (8.0) 19 (6.3) 6 (2.6) 74(6.4) 
Pearson chi2(2) = 
9.0799 Pr = 0.011 
Provided instruction to finish a full 
course 
47 (7.7) 20 (6.9) 6 (2.6) 73(6.4) 
Pearson chi2(2) = 
7.721 Pr = 0.021 
Quality of interaction additive score      
0 - no question asked or advice given 522 (85.3) 275 (90.5) 216 (93.1) 1013 (88.2) 
Pearson chi2 = 11.851 
Pr = 0.003 
1 question or piece of advice 35 (5.7) 6 (1.9) 4 (1.7) 45(3.9)  
2 questions or pieces of advice 28 (4.6) 14 (4.6) 9 (3.9) 51(4.4)  
3 questions or pieces of advice 18 (2.9) 8 (2.6) 0 26(2.3)  
4 questions or pieces of advice 6 (0.9) 1 (0.3) 0 7(0.6)  
5 questions or pieces of advice 2 (0.3) 0 0  2(0.2)  
6 questions or pieces of advice 1 (0.2) 0 0 1(0.1)  
7 questions or pieces of advice 0 0 3 (1.3) 3(0.3)  
Total with a score between 1–7 90 (14.7) 29 (9.5) 16 (6.9) 135 (11.7)  
a ‘Did not sell’ could be ‘refused to sell’, or ‘did not stock’, or ‘sold alternative drug instead of amoxicillin’. 
3.3. Other Antibiotics Dispensed without Prescription 
The MC scenario protocol required the MCs to ask for amoxicillin (with no prescrip-
tion) and only if questioned, to describe UTI symptoms, an ailment for which amoxicillin, 
if prescribed, would have been an appropriate treatment. Nevertheless, in a small minor-
ity of cases, sellers dispensed another antibiotic that had not been requested, instead of 
amoxicillin. Ampicloxacillin and ciprofloxacin were the most frequently sold alternatives 
(Table 3). 
Table 3. List of alternative drugs sold and number of sellers who sold them. 
Mwanza (n = 26) Mbeya (n = 13) Kilimanjaro (n = 1) 




Ampicloxacillin and Phenoxymethylpenicillin 
(1) 
 
Metronidazole (2) Azithromycin and Metronidazole (1)  
Azithromycin (2) Cephalexin (1)  
Ciprofloxacin (5)  Ciprofloxacin (4)   
Doxycycline (1) Doxycycline and Metronidazole (1)  
Trimethoprim/sulfamethoxazole (3) Nitrofurantoin and Azithromycin (1)   
Doxycycline and Azithromycin (1) PenV (1)  
 Trimethoprim/sulfamethoxazole (1)  
 Trimethoprim/sulfamethoxazole (1)  
3.4. Differences between ADDOs and Pharmacies Regarding Dispenisng Practices 
Cognizant of the significant difference in the absolute numbers of ADDOs vs. com-
munity pharmacies (see Figure 3), we disaggregated dispensing amoxicillin without pre-
scription by seller type. No significant difference was observed in terms of dispensing 
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between ADDOs and community pharmacies in Mwanza region (84.9% vs. 87.5%, chi2 = 
0.357 and p = value 0.550), and while dispensing without prescription was higher in AD-
DOs in Mbeya (96.9% vs. 82.2%, chi2 = 4.154 and p = 0.042) and Kilimanjaro (94.7% vs. 
77.3, chi2 = 9.486 and p = 0.002), over two-thirds of pharmacies dispensed without pre-
scription in all regions. 
 
Figure 3. Proportion of sellers dispensing without prescription, according to types of outlets across 
three regions. 
With regard to the quality of interaction recorded in Table 2 (questions asked and 
advice given), the difference between ADDOs and pharmacies was as follows: in Mbeya 
and Kilimanjaro, 17.8% and 22.7%, respectively, of pharmacies addressed at least one of 
the seven question or advice items before selling amoxicillin compared to only 8.1% and 
5.2% of the sellers from ADDOs. However, no statistical difference was observed between 
different types of sellers in Mwanza (community pharmacies 12.5%, ADDOs 15.04% 
chi2=0.357 and p = value 0.550) (Figure 3). 
Figure 4 shows differences in dispensing amoxicillin according to urban/rural areas 
of the three regions. Whilst in Kilimanjaro and Mwanza, the likelihood of selling antibiot-
ics without prescription was over 10% higher among rural outlets compared with those 
located in urban areas, the differences were not statistically significant. The likelihood of 
selling ABs was between 82–9% in all areas (Figure 4). 




Figure 4. Location of outlets dispensing amoxicillin without prescription in three regions. 
4. Discussion 
As part of a wider three-country investigation of the drivers of AMR in East Africa, 
this study aimed to explore the role played by private drug shops in the antibiotic provi-
sion landscape in three sites in Tanzania (Mwanza, Mbeya and Kilimanjaro regions). The 
Tanzania Food, Drugs and Cosmetics (Scheduling of Medicines) Regulations [13] prohibit 
the sale of antibiotics without prescription. We investigated how different kinds of drug 
sellers, in different contexts, would respond to a request for a common antibiotic (amoxi-
cillin) from a client who did not have a prescription and who did not initially describe 
their symptoms (indicative of a UTI). 
Our findings indicate that more than 90% of all community pharmacies and ADDO 
surveyed across the three regions dispensed antibiotics without prescription. This is 
higher than both the figures reported for Africa (62%) and North America (74%) in a recent 
38 study systematic review [31] and the findings of a previous study conducted in 
Morogoro, Tanzania (85%) [25]. Study design might explain some of the difference in the 
findings. Our MC scenario was based on a condition for which a doctor might reasonably 
write an antibiotic prescription (e.g., probable UTI infection), whilst other studies some-
times describe conditions that would not. Additionally, it should be noted that our MCs 
were both men and women, and recommended treatment for UTI can differ between 
males and females. However, in both cases, it is worth remembering that few sellers in 
our study asked the relevant questions that would allow them to identify the MC’s con-
dition (less than 1% asked to see a prescription and less than 10% asked about symptoms). 
Therefore, our study seems to corroborate the findings of a 2018 urban-only study in Kil-
imanjaro region that reported 92.3% of surveyed community pharmacies dispensed anti-
biotics without prescription [24] and extends these findings to cover rural areas as well. 
Our scenario tested not only the outcome of a request for amoxicillin without pre-
scription but also the quality of the interaction between sellers and clients at the point of 
sale. Across the study, interactions were recorded as almost universally poor with only 
11.75% of all sellers either asking questions or offering any advice to the client. Quality of 
interaction scores was differentiated by site, with Mwanza region having 90 (14.7%) of 
sellers with an interaction score of 1–7, whilst Mbeya had 29 (9.5%) and Kilimanjaro only 
16 (6.9%) (p-value 0.003). In all regions, less than 1.5% of sellers asked either for a prescrip-
tion or checked if clients were taking other medications. While instructions to buy or finish 
a full course were common suggestions among the minority that asked any questions or 
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gave any advice (6.4%), this did not prevent most from dispensing a half course, never-
theless. The better (but still poor) quality of interaction scores in Mwanza might relate to 
the presence of a medical university offering a diploma in pharmaceutical sciences and a 
bachelor’s in pharmacy and the likelihood that students work part-time in some commu-
nity pharmacies, but only further research could confirm this. The quality of interaction 
findings for this study, whilst specific to a particular context, are comparable with similar 
studies in other least developed and middle-income countries, for example, an Ethiopian 
study in which 11.8% of 422 sellers asked at least one question [32] and a Pakistani study 
that recorded 11% of 353 sellers asked about medication history [33]. However, all these 
regional case studies compare poorly with a study from Shenyang, northern China (upper 
middle-income country) in which 82.3% asked at least one question [34]. The lack of sus-
tained monitoring of pharmacy conduct by the authorized bodies is among the likely rea-
sons for the poor level of seller-client interactions observed in this study. 
Importantly, our study not only investigated whether sellers would dispense antibi-
otics without prescription (something others have tested before), it also tested whether 
sellers would dispense a quantity of drugs below the regulated minimum-, or ‘full-’ 
course. This was an important question since sale of a partial dose may further compound 
the risk of AMR development. We found that 93.03% of sellers granted the client’s request 
for ‘only a few days’ worth.’ Of these, while a smaller number sold as ‘a half course,’ a 
quantity close to the ‘full course,’ the majority sold half or less of that quantity. Only six 
sellers insisted that they buy a full course. 
Comparing our data on both urban and rural areas, sellers in rural areas were more 
likely to dispense amoxicillin without prescription than those in urban areas. In Mwanza, 
of 425 outlets located in urban areas, 84% sold amoxicillin without prescription compared 
to 92% of 187 outlets located in rural areas, p = 0.014. Significant difference was also ob-
served in Kilimanjaro (urban n = 214, 93.3% vs. rural n = 90, 100%, p = 0.003). No significant 
difference was observed in Mbeya (urban n = 425 and rural n = 187). This is similar to that 
reported in a recent Vietnamese study (88% urban and 91% rural) [35] where, whilst a 
very different context, more sellers in rural than urban areas were also dispensing antibi-
otics without prescription. Some of the rural-urban difference in Tanzania might be ex-
plained by the potentially greater difficulty of enforcing regulations in rural areas, or that 
there is less health care and laboratory infrastructure and fewer qualified personnel to 
appropriately implement and enforce the regulations [16]. However, on these grounds, it 
is surprising that the difference between rural and urban areas is not greater than is ob-
served (see Figure 4). 
Meanwhile, sale of antibiotics without prescription was higher in ADDO shops than 
in community pharmacies. An explanation for this disparity might be sought in the likely 
differential in the level of pharmacy education of the persons operating the shops. In Tan-
zania law, a Part I pharmacy must be supervised by the registered pharmacist whilst a 
part II pharmacy can be supervised by anyone who has completed the five weeks’ training 
on accredited drugs dispensing outlets (ADDO) [12]. However, these significant differ-
ences in qualification do not seem to translate into radically different dispensing practices; 
the lowest rate for pharmacies selling without prescription was 77% (Kilimanjaro) in 
Mwanza and Mbeya it was over 80%. Therefore, something other than qualifications, or 
lack thereof, must be driving the common practice of dispensing without a prescription. 
One possible driver of the observed prescription practice in this study may be the 
relative abundance of drug sellers and the likely impact this has on market forces. Such a 
distribution was one of the criticisms leveled at the “Duka La Dawa Baridi” (DLDB) struc-
ture of small drug shops that the ADDO regulation was created to replace [16]. More than 
this, whereas regulations require a spatial separation of 500 m between pharmacies and 
300 m between ADDOs in small towns and 200 m in rural areas [14] our study recorded 
instances where these separations were not respected. A forthcoming paper will explore 
these geographic drivers in more detail. 
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Recently, Tanzania was the first African country to be recognized by the WHO as 
having achieved a well-functioning regulatory system for medical products (achieved 
through Tanzania Food and Drugs Authority (TFDA) now known as Tanzania Medicines 
and Medical Devices Authority (TMDA) [14]. If fully implemented, these regulations 
should ensure patient safety and curtail the development of AMR. However, while the 
infrastructure of regulation may exist, the evidence from our study demonstrates that un-
der objective test conditions, the majority of sellers were willing to breach regulations and 
sell prescription antibiotics to a client who did not possess a prescription, and further-
more, most were prepared to sell a half course, with very few giving the advice that com-
pletion of a full course was recommended. Clearly, continuous training about antibiotic 
stewardship and antibiotic resistance, stricter enforcement of regulation and/or an in-
creased acquiescence to rules is required if Tanzania’s acclaimed system is to contribute 
effectively to the fight against AMR. However, further research is also needed on what 
motivates clients/patients to demand, and sellers to supply, antibiotics over the counter 
without prescription. Forthcoming work from the HATUA consortium that analyses qual-
itative interviews and focus groups with patients, community members, doctors, and 
drug sellers, as well as impact of the geographic proximity of sellers, hopes to illuminate 
these questions further. 
5. Limitations 
First, our MCs were both male and female, and yet UTI treatment for men and 
women is often different. However, the scenario used in the current study required the 
mystery client to request amoxicillin in the first instance and only report UTI symptoms 
if questioned. Second the scenario used in the current study required the mystery client 
to request amoxicillin rather than presenting symptoms and asking for a seller’s recom-
mendation. A scenario based on presenting symptoms and asking for advice on treatment 
may have resulted in more, or less dispensing of antibiotics and or a greater variety of 
antibiotics dispensed. A HATUA Phase 2 MC survey will test such a scenario. Third, each 
seller was visited only once, however, the consistency of response across multiple sellers 
offsets the lack of multiple visits to anyone seller. Fourth, the short delay between the MCs 
interaction in a drug shop, and their completion of the Epicollect log at a short distance 
from the shop is open to the possibility of recall bias. Fifth, within the limits of this paper 
it has not been possible to fully address the data on the geographic proximity of sellers. 
This will be addressed in forthcoming papers. 
6. Conclusions 
This project used a mystery client study (MCS) to explore the dispensing practices of 
private drug providers (both community pharmacies and ADDOs), in response to a sce-
nario in which a client, with no prescription, and not initially describing symptoms, asked 
for the antibiotic amoxicillin, and subsequently for a partial course. It did so via a near 
100% sample of sellers in both the rural and urban areas of three regions of Tanzania 
(Mwanza, Mbeya and Kilimanjaro). The study’s contribution is to offer, from multiple 
sites and on a scale not yet seen in Tanzania, objective data on antibiotic dispensing prac-
tices, and also to offer insights on the quality of seller-client interaction at the point of sale; 
both of which can inform policy around antibiotic stewardship in this and other majority 
world contexts. 
The study findings reveal that unprescribed antibiotics are commonly dispensed and 
sold in community pharmacies and ADDOs across the country. It demonstrates that while 
such dispensing is more common among ADDOs than community pharmacies, and in 
rural areas (where ADDOs predominate) than in urban areas, it is nevertheless the most 
common practice in all sectors, contexts, and regions. Furthermore, the study reveals that 
(in the context of the tested scenario), the quality of the interaction between sellers and 
clients, in terms of clinically relevant questions asked and antibiotic stewardship relevant 
advice given is almost universally poor. 
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Further research is needed to better understand the motivations of providers and 
consumers, and how these vary by location and regulatory context. This will require more 
subtle MCS scenarios, for example, that test seller responses to the description of symp-
toms likely to benefit from a course of antibiotics, rather than a straightforward demand 
of a given drug, to test whether dispensing without a prescription remains common and 
whether the quality of questioning and advice improves. 
The detailed knowledge emerging from this (and the broader HATUA) study is vital 
in planning interventions to address the problems of inappropriate demand and provision 
of antibiotics and ultimately, antibiotic resistance. 
Our recommendations based on this study are that immediate action needs to be 
taken by the Ministry of Health Community Development, Gender, Elderly and Children 
in creating awareness and understanding on antibiotic resistance through effective infor-
mation, education, and communication among different audiences in the community in-
cluding school settings, village assemblies, health facilities and political gatherings. This 
will help in promoting behavior change for both antibiotic sellers and consumers. 
Supplementary Materials: The following are available online at www.mdpi.com/2079-
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